{"id":78759,"date":"2026-02-23T11:05:33","date_gmt":"2026-02-23T10:05:33","guid":{"rendered":"https:\/\/www.embl.org\/news\/?p=78759"},"modified":"2026-02-23T11:47:39","modified_gmt":"2026-02-23T10:47:39","slug":"illumina-joins-embl-corporate-partnership-programme","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/","title":{"rendered":"Illumina joins EMBL Corporate Partnership Programme"},"content":{"rendered":"\n<p>The biotechnology company Illumina has become the newest member of EMBL\u2019s <a href=\"https:\/\/www.embl.org\/about\/info\/support\/embl-corporate-partnership-programme\/\">Corporate Partnership Programme (CPP)<\/a>. It rejoins the programme after a 10-year hiatus.<\/p>\n\n\n\n<p>Headquartered in San Diego, California, Illumina is a global genomics and human health company engaged in precision health advancements. Previously, it was a CPP member from 2010\u20132015.&nbsp;<\/p>\n\n\n\n<p>&#8220;I am delighted to see Illumina\u2019s return to the CPP family. This marks an excellent opportunity to further strengthen a very good relationship between our two organisations,\u201d said Vladimir Benes, head of EMBL\u2019s Genomics Core Facility. &#8220;I am confident that the CPP membership will further enhance our joint activities, particularly in the area of training, where both organisations have an established, successful track record.\u201d<\/p>\n\n\n\n<p>CPP members benefit from direct connection with EMBL\u2019s world-leading molecular biology research, services, and technology development, and their support enables EMBL to provide additional training opportunities for the next generation of molecular biologists. Specifically, members support EMBL\u2019s scientific training and conferences programme fellowships, as well as the scientific visitor programme, and participate in discussions of future conference topics and practical courses.<\/p>\n\n\n\n<p>\u201cBeing part of the EMBL Corporate Partnership Programme underscores Illumina\u2019s dedication to enabling the power of genomics for all,\u201d said Markus Vossmann, Illumina\u2019s General Manager, Germany. \u201cEMBL\u2019s collaborative ecosystem aligns perfectly with our mission.\u201d<\/p>\n\n\n\n<p>He added, \u201cThrough this partnership, Illumina and EMBL will foster scientific exchange, accelerate translational research, and support groundbreaking discoveries that shape the future of biological sciences. Together, we aim to create opportunities for joint initiatives, knowledge sharing, and impactful collaborations that empower researchers worldwide.\u201d<\/p>\n\n\n\n<p>For more information on the EMBL CPP, visit the newly updated <a href=\"https:\/\/www.embl.org\/about\/info\/support\/embl-corporate-partnership-programme\/\">CPP website<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The biotechnology and genomics research company Illumina joins EMBL\u2019s Corporate Partnership Programme, supporting training opportunities for next-generation scientists.<\/p>\n","protected":false},"author":100,"featured_media":78763,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17597],"tags":[172,71,796,13072,27],"embl_taxonomy":[19535,5802,2070],"class_list":["post-78759","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-embl-announcements","tag-corporate-partnership-programme","tag-industry","tag-ord","tag-support-embl","tag-training","embl_taxonomy-corporate-partnership-programme","embl_taxonomy-support-embl","embl_taxonomy-training-and-development"],"acf":{"vfwp-news_embl_taxonomy":[5802,2070,19535],"featured":true,"show_featured_image":false,"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"article_intro":"<p>Genomics research company focused on precision health advancements<\/p>\n","related_links":[{"link_description":"EMBL Corporate Partnership Programme","link_url":"https:\/\/www.embl.org\/about\/info\/support\/embl-corporate-partnership-programme\/"}],"source_article":false,"in_this_article":false,"press_contact":"None","article_translations":false,"languages":""},"embl_taxonomy_terms":[{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"69e1d012-360d-4754-bf0f-9e1185643e9f\";i:2;s:36:\"0d3270ca-455c-428a-86f4-c61b1de8c3e0\";}","parents":[],"name":["Corporate Partnership Programme"],"slug":"corporate-partnership-programme","description":"What &gt; Support EMBL &gt; Corporate Partnership Programme"},{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"bc1eaadd-1f50-4140-8e9b-e58fc33a39fc\";i:2;s:36:\"69e1d012-360d-4754-bf0f-9e1185643e9f\";}","parents":[],"name":["Support EMBL"],"slug":"support-embl","description":"What &gt; About EMBL &gt; Support EMBL"},{"uuid":"a:2:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"cac5b899-a450-4f36-a445-8508ae6b1134\";}","parents":[],"name":["Training and development"],"slug":"training-and-development","description":"What &gt; Training and development"}],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Illumina joins EMBL Corporate Partnership Programme | EMBL<\/title>\n<meta name=\"description\" content=\"The biotechnology and genomics research company Illumina joins EMBL\u2019s Corporate Partnership Programme, supporting training opportunities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Illumina joins EMBL Corporate Partnership Programme | EMBL\" \/>\n<meta property=\"og:description\" content=\"The biotechnology and genomics research company Illumina joins EMBL\u2019s Corporate Partnership Programme, supporting training opportunities.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-23T10:05:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-23T10:47:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ivy Kupec\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ivy Kupec\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/\"},\"author\":{\"name\":\"Ivy Kupec\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274\"},\"headline\":\"Illumina joins EMBL Corporate Partnership Programme\",\"datePublished\":\"2026-02-23T10:05:33+00:00\",\"dateModified\":\"2026-02-23T10:47:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/\"},\"wordCount\":280,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg\",\"keywords\":[\"corporate partnership programme\",\"industry\",\"ord\",\"support embl\",\"training\"],\"articleSection\":[\"EMBL Announcements\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/\",\"url\":\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/\",\"name\":\"Illumina joins EMBL Corporate Partnership Programme | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg\",\"datePublished\":\"2026-02-23T10:05:33+00:00\",\"dateModified\":\"2026-02-23T10:47:39+00:00\",\"description\":\"The biotechnology and genomics research company Illumina joins EMBL\u2019s Corporate Partnership Programme, supporting training opportunities.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg\",\"width\":1000,\"height\":600,\"caption\":\"EMBL\u2019s Corporate Partnership Programme Lead Nadine Ilk (left) and Head of Genomics Core Facility Vladimir Benes (right) officially welcomed Illumina to the CPP programme at the recent annual meeting in Heidelberg. Markus Vossmann (middle), Illumina\u2019s General Manager, Germany, joined these two at EMBL\u2019s genomics core facility, GeneCore, at that time. Credit: Joseph Franciosa\/EMBL\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274\",\"name\":\"Ivy Kupec\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g\",\"caption\":\"Ivy Kupec\"},\"url\":\"https:\/\/www.embl.org\/news\/author\/ivy-kupecembl-de\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Illumina joins EMBL Corporate Partnership Programme | EMBL","description":"The biotechnology and genomics research company Illumina joins EMBL\u2019s Corporate Partnership Programme, supporting training opportunities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/","og_locale":"en_US","og_type":"article","og_title":"Illumina joins EMBL Corporate Partnership Programme | EMBL","og_description":"The biotechnology and genomics research company Illumina joins EMBL\u2019s Corporate Partnership Programme, supporting training opportunities.","og_url":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2026-02-23T10:05:33+00:00","article_modified_time":"2026-02-23T10:47:39+00:00","og_image":[{"width":1000,"height":600,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg","type":"image\/jpeg"}],"author":"Ivy Kupec","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Ivy Kupec","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/"},"author":{"name":"Ivy Kupec","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274"},"headline":"Illumina joins EMBL Corporate Partnership Programme","datePublished":"2026-02-23T10:05:33+00:00","dateModified":"2026-02-23T10:47:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/"},"wordCount":280,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg","keywords":["corporate partnership programme","industry","ord","support embl","training"],"articleSection":["EMBL Announcements"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/","url":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/","name":"Illumina joins EMBL Corporate Partnership Programme | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg","datePublished":"2026-02-23T10:05:33+00:00","dateModified":"2026-02-23T10:47:39+00:00","description":"The biotechnology and genomics research company Illumina joins EMBL\u2019s Corporate Partnership Programme, supporting training opportunities.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/embl-announcements\/illumina-joins-embl-corporate-partnership-programme\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg","width":1000,"height":600,"caption":"EMBL\u2019s Corporate Partnership Programme Lead Nadine Ilk (left) and Head of Genomics Core Facility Vladimir Benes (right) officially welcomed Illumina to the CPP programme at the recent annual meeting in Heidelberg. Markus Vossmann (middle), Illumina\u2019s General Manager, Germany, joined these two at EMBL\u2019s genomics core facility, GeneCore, at that time. Credit: Joseph Franciosa\/EMBL"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/427f2c9b624bc32ffa67d80414712274","name":"Ivy Kupec","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1abc86f00519d61bc0f2793ed624175c2d7ad829fb5b60e1c3b99a973ac351a6?s=96&d=mm&r=g","caption":"Ivy Kupec"},"url":"https:\/\/www.embl.org\/news\/author\/ivy-kupecembl-de\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/02\/CPP-Illumina-new-member.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/78759","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/100"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=78759"}],"version-history":[{"count":4,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/78759\/revisions"}],"predecessor-version":[{"id":78769,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/78759\/revisions\/78769"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/78763"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=78759"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=78759"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=78759"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=78759"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}